Cite
Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS).
MLA
Babaahmadi, Rezaei, Hossein, et al. “Comparison of Atherogenic Indices for Predicting the Risk of Metabolic Syndrome in Southwest Iran: Results from the Hoveyzeh Cohort Study (HCS).” Diabetology & Metabolic Syndrome, vol. 16, no. 1, May 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13098-024-01349-1.
APA
Babaahmadi, R. H., Raeisizadeh, M., Zarezade, V., Noemani, K., Mashkournia, A., & Ghaderi-Zefrehi, H. (2024). Comparison of atherogenic indices for predicting the risk of metabolic syndrome in Southwest Iran: results from the Hoveyzeh Cohort Study (HCS). Diabetology & Metabolic Syndrome, 16(1), 1–9. https://doi.org/10.1186/s13098-024-01349-1
Chicago
Babaahmadi, Rezaei, Hossein, Maedeh Raeisizadeh, Vahid Zarezade, Kourosh Noemani, Ahmad Mashkournia, and Hossein Ghaderi-Zefrehi. 2024. “Comparison of Atherogenic Indices for Predicting the Risk of Metabolic Syndrome in Southwest Iran: Results from the Hoveyzeh Cohort Study (HCS).” Diabetology & Metabolic Syndrome 16 (1): 1–9. doi:10.1186/s13098-024-01349-1.